Today someone asked me to review an article published in The Lancet, titled, “Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial (https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00485-0/fulltext?fbclid=IwAR0A-7A34yvpYrviTX5zZ1PBHwUxyRKGpGuR5QRUQrSNsqzegeyhPJHU3jE).
The article appears to be considered a scientific study (because it is published in The Lancet) conducted in a hospital environment. So the question asked, “Dr could you tell me if what I’m reading here means remdesivir is worse for patients.”
I prefer not to respond from the scientific perspective and evaluation because such studies are to trick the public into convincing that COVID-19 (and its associated virus) exists. In the summary section (second sentence), it is stated, “We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with standard of care alone in patients admitted to hospital with COVID-19, with indication of oxygen or ventilator support.”
Scientifically speaking, there has been no evidence available or provided that “COVID-19” exists. For a COVID-19 to exist, the presence of the virus must be established in humans. However, that has not been done so far. Hence there cannot be COVID-19. Period! Therefore, treating the imaginary illness just does not make sense. It is purely a marketing strategy for promoting diseases and medicines.
Unfortunately, collecting some subjects and treating them with potent chemicals is a terrible practice, certainly not scientific or logical. Instead, they should re-evaluate the patients and their illness and relate it to some measurable endpoint using scientifically valid tests for the illness or the virus (if it exists). Without such an approach, one can obtain any outcome at random with any treatment. Therefore, consider ignoring and discouraging such non-scientific studies for promoting the disease or its treatments.